The multifaceted nature of antimicrobial peptides: current synthetic chemistry approaches and future directions

Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness

Nishita, M., Park, S.-Y., Nishio, T., Kamizaki, K., Wang, Z., Tamada, K., Takumi, T., Hashimoto, R., Otani, H., Pazour, G. J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-016-0028-x · Cited by 15,947

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

Magiorakos, A.-P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03570.x · Cited by 14,449

Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide

Merrifield, R. B. (1963) · Journal of the American Chemical Society · doi:10.1021/ja00897a025 · Cited by 7,647

Structural absorption by barbule microstructures of super black bird of paradise feathers

McCoy, D. E., Feo, T., Harvey, T. A., & Prum, R. O. (2018) · Nature Communications · doi:10.1038/s41467-017-02088-w · Cited by 7,424

Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury

Mehta, R. L., Kellum, J. A., Shah, S. V., Molitoris, B. A., Ronco, C., Warnock, D. G., Levin, A., & the Acute Kidney Injury Network (2007) · Critical Care · doi:10.1186/cc5713 · Cited by 7,048

Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?

Brogden, K. A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1098 · Cited by 5,829

Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study

Liu, Y.-Y., Wang, Y., Walsh, T. R., Yi, L.-X., Zhang, R., Spencer, J., Doi, Y., Tian, G., Dong, B., Huang, X., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00424-7 · Cited by 5,398

Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis

Meijer, L., Nelson, D. J., Riazanski, V., Gabdoulkhakova, A. G., Hery-Arnaud, G., Le Berre, R., Loaëc, N., Oumata, N., Galons, H., Nowak, E., et al. (2016) · Journal of Innate Immunity · doi:10.1159/000444256 · Cited by 4,992

A New Class of Polymers: Starburst-Dendritic Macromolecules

Tomalia, D. A., Baker, H., Dewald, J., Hall, M., Kallos, G., Martin, S., Roeck, J., Ryder, J., & Smith, P. (1985) · Polymer Journal · doi:10.1295/polymj.17.117 · Cited by 3,904

Mechanisms of Antimicrobial Peptide Action and Resistance

Yeaman, M. R., & Yount, N. Y. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.2 · Cited by 3,001

Antibiotic resistance: a rundown of a global crisis

Aslam, B., Wang, W., Arshad, M. I., Khurshid, M., Muzammil, S., Rasool, M. H., Nisar, M. A., Alvi, R. F., Aslam, M. A., Qamar, M. U., et al. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s173867 · Cited by 2,552

Peptide Antimicrobial Agents

Jenssen, H., Hamill, P., & Hancock, R. E. W. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00056-05 · Cited by 2,518

Bacillus lipopeptides: versatile weapons for plant disease biocontrol

Ongena, M., & Jacques, P. (2008) · Trends in Microbiology · doi:10.1016/j.tim.2007.12.009 · Cited by 2,418

Preparation of polymers with controlled molecular architecture. A new convergent approach to dendritic macromolecules

Hawker, C. J., & Frechet, J. M. J. (1990) · Journal of the American Chemical Society · doi:10.1021/ja00177a027 · Cited by 2,413

APD3: the antimicrobial peptide database as a tool for research and education

Wang, G., Li, X., & Wang, Z. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1278 · Cited by 2,388

Physiological heterogeneity in biofilms

Stewart, P. S., & Franklin, M. J. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1838 · Cited by 2,327

Antibacterial drug discovery in the resistance era

Brown, E. D., & Wright, G. D. (2016) · Nature · doi:10.1038/nature17042 · Cited by 2,247

Overview of the immune response

Chaplin, D. D. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.12.980 · Cited by 2,235

Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature

Arnison, P. G., Bibb, M. J., Bierbaum, G., Bowers, A. A., Bugni, T. S., Bulaj, G., Camarero, J. A., Campopiano, D. J., Challis, G. L., Clardy, J., et al. (2013) · Nat. Prod. Rep. · doi:10.1039/c2np20085f · Cited by 2,076

Efficient generation of mouse models of human diseases via ABE- and BE-mediated base editing

Liu, Z., Lu, Z., Yang, G., Huang, S., Li, G., Feng, S., Liu, Y., Li, J., Yu, W., Zhang, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04768-7 · Cited by 2,074

Persister cells, dormancy and infectious disease

Lewis, K. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1557 · Cited by 2,052

Designing antimicrobial peptides: form follows function

Fjell, C. D., Hiss, J. A., Hancock, R. E. W., & Schneider, G. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3591 · Cited by 2,035

The third helix of the Antennapedia homeodomain translocates through biological membranes.

Derossi, D., Joliot, A. H., Chassaing, G., & Prochiantz, A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34080-2 · Cited by 2,034

Riddle of Biofilm Resistance

Lewis, K. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.999-1007.2001 · Cited by 1,980

Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review

Mulani, M. S., Kamble, E. E., Kumkar, S. N., Tawre, M. S., & Pardesi, K. R. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00539 · Cited by 1,644

Sepsis and septic shock

Hotchkiss, R. S., Moldawer, L. L., Opal, S. M., Reinhart, K., Turnbull, I. R., & Vincent, J.-L. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.45 · Cited by 1,620

Antimicrobial host defence peptides: functions and clinical potential

Mookherjee, N., Anderson, M. A., Haagsman, H. P., & Davidson, D. J. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0058-8 · Cited by 1,502

Nucleic acid-based approaches to investigate microbial-related cheese quality defects

O'Sullivan, D. J., Giblin, L., McSweeney, P. L. H., Sheehan, J. J., & Cotter, P. D. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00001 · Cited by 1,417

Membrane lipid homeostasis in bacteria

Zhang, Y.-M., & Rock, C. O. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1839 · Cited by 1,393

Definitions and guidelines for research on antibiotic persistence

Balaban, N. Q., Helaine, S., Lewis, K., Ackermann, M., Aldridge, B., Andersson, D. I., Brynildsen, M. P., Bumann, D., Camilli, A., Collins, J. J., et al. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0196-3 · Cited by 1,313

Studies on anticancer activities of antimicrobial peptides

Hoskin, D. W., & Ramamoorthy, A. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.11.008 · Cited by 1,296

Surfactant Protein-A Binds Group B Streptococcus Enhancing Phagocytosis and Clearance from Lungs of Surfactant Protein-A–Deficient Mice

LeVine, A. M., Kurak, K. E., Wright, J. R., Watford, W. T., Bruno, M. D., Ross, G. F., Whitsett, J. A., & Korfhagen, T. R. (1999) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.20.2.3303 · Cited by 1,273

Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system.

Tam, J. P. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.15.5409 · Cited by 1,251

Antimicrobial Peptides: Diversity, Mechanism of Action and Strategies to Improve the Activity and Biocompatibility In Vivo

Kumar, P., Kizhakkedathu, J., & Straus, S. (2018) · Biomolecules · doi:10.3390/biom8010004 · Cited by 1,227

Dendrimers in drug research

Boas, U., & Heegaard, P. M. H. (2004) · Chemical Society Reviews · doi:10.1039/b309043b · Cited by 1,175

The value of antimicrobial peptides in the age of resistance

Magana, M., Pushpanathan, M., Santos, A. L., Leanse, L., Fernandez, M., Ioannidis, A., Giulianotti, M. A., Apidianakis, Y., Bradfute, S., Ferguson, A. L., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30327-3 · Cited by 1,150

The antimicrobial peptides and their potential clinical applications.

Lei, J., Sun, L., Huang, S., Zhu, C., Li, P., He, J., Mackey, V., Coy, D. H., & He, Q. (2019) · PubMed · Cited by 1,116

The global threat of antimicrobial resistance: science for intervention.

Roca, I., Akova, M., Baquero, F., Carlet, J., Cavaleri, M., Coenen, S., Cohen, J., Findlay, D., Gyssens, I., Heure, O. E., et al. (2015) · New Microbes and New Infections · doi:10.1016/j.nmni.2015.02.007 · Cited by 1,106

The asymmetric distribution of phospholipids in the human red cell membrane. A combined study using phospholipases and freeze-etch electron microscopy

Verkleij, A. J., Zwaal, R. F. A., Roelofsen, B., Comfurius, P., Kastelijn, D., & van Deenen, L. L. M. (1973) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(73)90143-0 · Cited by 1,106

Human β-Defensin-1 Is a Salt-Sensitive Antibiotic in Lung That Is Inactivated in Cystic Fibrosis

Goldman, M. J., Anderson, G. M., Stolzenberg, E. D., Kari, U. P., Zasloff, M., & Wilson, J. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81895-4 · Cited by 1,080

Antimicrobial peptides: Application informed by evolution

Lazzaro, B. P., Zasloff, M., & Rolff, J. (2020) · Science · doi:10.1126/science.aau5480 · Cited by 1,069

Influence of pH on wound-healing: a new perspective for wound-therapy?

Schneider, L. A., Korber, A., Grabbe, S., & Dissemond, J. (2007) · Archives of Dermatological Research · doi:10.1007/s00403-006-0713-x · Cited by 1,066

Cystic Fibrosis Airway Epithelia Fail to Kill Bacteria Because of Abnormal Airway Surface Fluid

Smith, J. J., Travis, S. M., Greenberg, E. P., & Welsh, M. J. (1996) · Cell · doi:10.1016/s0092-8674(00)81099-5 · Cited by 1,039

Describing the Mechanism of Antimicrobial Peptide Action with the Interfacial Activity Model

Wimley, W. C. (2010) · ACS Chemical Biology · doi:10.1021/cb1001558 · Cited by 1,001

Glucose Metabolism Regulates T Cell Activation, Differentiation, and Functions

Palmer, C. S., Ostrowski, M., Balderson, B., Christian, N., & Crowe, S. M. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00001 · Cited by 988

Nonribosomal Peptide Synthesis—Principles and Prospects

Süssmuth, R. D., & Mainz, A. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201609079 · Cited by 958

APD2: the updated antimicrobial peptide database and its application in peptide design.

Wang, G., Li, X., & Wang, Z. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn823 · Cited by 941

Antibacterial agents based on the cyclic d,l-α-peptide architecture

Fernandez-Lopez, S., Kim, H.-S., Choi, E. C., Delgado, M., Granja, J. R., Khasanov, A., Kraehenbuehl, K., Long, G., Weinberger, D. A., Wilcoxen, K. M., et al. (2001) · Nature · doi:10.1038/35086601 · Cited by 938

Macrocyclic Peptides as Drug Candidates: Recent Progress and Remaining Challenges

Vinogradov, A. A., Yin, Y., & Suga, H. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.8b13178 · Cited by 848

Early Use of Polymyxin B Hemoperfusion in Abdominal Septic Shock: The EUPHAS Randomized Controlled Trial

Cruz, D. N., Antonelli, M., Fumagalli, R., Foltran, F., Brienza, N., Donati, A., Malcangi, V., Petrini, F., Volta, G., Bobbio Pallavicini, F. M., et al. (2009) · JAMA · doi:10.1001/jama.2009.856 · Cited by 832

Toxicity of polymyxins: a systematic review of the evidence from old and recent studies

Falagas, M. E., & Kasiakou, S. K. (2006) · Critical Care · doi:10.1186/cc3995 · Cited by 828

Combating multidrug-resistant Gram-negative bacteria with structurally nanoengineered antimicrobial peptide polymers

Lam, S. J., O'Brien-Simpson, N. M., Pantarat, N., Sulistio, A., Wong, E. H. H., Chen, Y.-Y., Lenzo, J. C., Holden, J. A., Blencowe, A., Reynolds, E. C., et al. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.162 · Cited by 821

Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides

Morrison, D. C., & Jacobs, D. M. (1976) · Immunochemistry · doi:10.1016/0019-2791(76)90181-6 · Cited by 819

Cell-penetrating peptides: classes, origin, and current landscape

Milletti, F. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.03.002 · Cited by 813

APD: the Antimicrobial Peptide Database

Wang, Z. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh025 · Cited by 808

Multidrug Tolerance of Biofilms and Persister Cells

Lewis, K. (2008) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-540-75418-3_6 · Cited by 804

Specific Binding of Nisin to the Peptidoglycan Precursor Lipid II Combines Pore Formation and Inhibition of Cell Wall Biosynthesis for Potent Antibiotic Activity

Wiedemann, I., Breukink, E., van Kraaij, C., Kuipers, O. P., Bierbaum, G., de Kruijff, B., & Sahl, H.-G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006770200 · Cited by 790

New developments in RiPP discovery, enzymology and engineering

Montalbán-López, M., Scott, T. A., Ramesh, S., Rahman, I. R., van Heel, A. J., Viel, J. H., Bandarian, V., Dittmann, E., Genilloud, O., Goto, Y., et al. (2021) · Natural Product Reports · doi:10.1039/d0np00027b · Cited by 787

Structure−Activity Relationships of Polymyxin Antibiotics

Velkov, T., Thompson, P. E., Nation, R. L., & Li, J. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm900999h · Cited by 780

Identification of a novel plasmid-mediated colistin-resistance gene, mcr-2, in Escherichia coli, Belgium, June 2016

Xavier, B. B., Lammens, C., Ruhal, R., Kumar-Singh, S., Butaye, P., Goossens, H., & Malhotra-Kumar, S. (2016) · Eurosurveillance · doi:10.2807/1560-7917.es.2016.21.27.30280 · Cited by 779

Multicomponent therapeutics for networked systems

Keith, C. T., Borisy, A. A., & Stockwell, B. R. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1609 · Cited by 769

Role of Peptide Hydrophobicity in the Mechanism of Action of α-Helical Antimicrobial Peptides

Chen, Y., Guarnieri, M. T., Vasil, A. I., Vasil, M. L., Mant, C. T., & Hodges, R. S. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00925-06 · Cited by 757

An Introduction to Medicinal Chemistry

Patrick, G. L. (2023) · Oxford University Press eBooks · doi:10.1093/hesc/9780198866664.001.0001 · Cited by 756

Cyclic peptide therapeutics: past, present and future

Zorzi, A., Deyle, K., & Heinis, C. (2017) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2017.02.006 · Cited by 737

Structure‐Based Design of Inhibitors of Protein–Protein Interactions: Mimicking Peptide Binding Epitopes

Pelay‐Gimeno, M., Glas, A., Koch, O., & Grossmann, T. N. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201412070 · Cited by 717

Control of cell selectivity of antimicrobial peptides

Matsuzaki, K. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.09.013 · Cited by 713

Role of lipids in the interaction of antimicrobial peptides with membranes

Teixeira, V., Feio, M. J., & Bastos, M. (2012) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.12.005 · Cited by 692

RAD51B in Familial Breast Cancer

Pelttari, L. M., Khan, S., Vuorela, M., Kiiski, J. I., Vilske, S., Nevanlinna, V., Ranta, S., Schleutker, J., Winqvist, R., Kallioniemi, A., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0153788 · Cited by 669

Molecular mechanisms of membrane targeting antibiotics

Epand, R. M., Walker, C., Epand, R. F., & Magarvey, N. A. (2016) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.10.018 · Cited by 666

Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides

Chongsiriwatana, N. P., Patch, J. A., Czyzewski, A. M., Dohm, M. T., Ivankin, A., Gidalevitz, D., Zuckermann, R. N., & Barron, A. E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708254105 · Cited by 657

PmrA–PmrB‐regulated genes necessary for 4‐aminoarabinose lipid A modification and polymyxin resistance

Gunn, J. S., Lim, K. B., Krueger, J., Kim, K., Guo, L., Hackett, M., & Miller, S. I. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.00757.x · Cited by 655

Facile synthesis of block copolypeptides of defined architecture

Deming, T. J. (1997) · Nature · doi:10.1038/37084 · Cited by 653

Spotlight on protein N-terminal acetylation

Ree, R., Varland, S., & Arnesen, T. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0116-z · Cited by 646

Ion Concentration Polarization by Bifurcated Current Path

Kim, J., Cho, I., Lee, H., & Kim, S. J. (2017) · Scientific Reports · doi:10.1038/s41598-017-04646-0 · Cited by 644

Antibiotics: Actions, Origins, Resistance

Walsh, C. (2003) · Wiley eBooks · doi:10.1128/9781555817886 · Cited by 633

Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis

Sota, J., Insalaco, A., Cimaz, R., Alessio, M., Cattalini, M., Gallizzi, R., Maggio, M. C., Lopalco, G., La Torre, F., Fabiani, C., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01526 · Cited by 616

Membrane Active Antimicrobial Peptides: Translating Mechanistic Insights to Design

Li, J., Koh, J.-J., Liu, S., Lakshminarayanan, R., Verma, C. S., & Beuerman, R. W. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00073 · Cited by 611

Rational Design of α-Helical Antimicrobial Peptides with Enhanced Activities and Specificity/Therapeutic Index

Chen, Y., Mant, C. T., Farmer, S. W., Hancock, R. E. W., Vasil, M. L., & Hodges, R. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413406200 · Cited by 600

Development and Challenges of Antimicrobial Peptides for Therapeutic Applications

Chen, C. H., & Lu, T. K. (2020) · Antibiotics · doi:10.3390/antibiotics9010024 · Cited by 598

Multidrug-Resistant Bacteria in the Community

van Duin, D., & Paterson, D. L. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2016.02.004 · Cited by 584

Molecular Medical Microbiology

(2015) · Elsevier eBooks · doi:10.1016/c2010-1-67744-9 · Cited by 579

Role of membranes in the activities of antimicrobial cationic peptides

Hancock, R. (2002) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(01)00480-3 · Cited by 574

Solid-Phase Peptide Synthesis. III. An Improved Synthesis of Bradykinin*

Merrifield, R. B. (1964) · Biochemistry · doi:10.1021/bi00897a032 · Cited by 572

Highly Efficient Synthesis of Covalently Cross-Linked Peptide Helices by Ring-Closing Metathesis

Blackwell, H. E., & Grubbs, R. H. (1998) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19981217)37:23<3281::aid-anie3281>3.0.co;2-v · Cited by 558

Immunoglobulin Analysis Tool: A Novel Tool for the Analysis of Human and Mouse Heavy and Light Chain Transcripts

Rogosch, T., Kerzel, S., Hoi, K. H., Zhang, Z., Maier, R. F., Ippolito, G. C., & Zemlin, M. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00176 · Cited by 555

Peptidomimetic Antibiotics Target Outer-Membrane Biogenesis in Pseudomonas aeruginosa

Srinivas, N., Jetter, P., Ueberbacher, B. J., Werneburg, M., Zerbe, K., Steinmann, J., Van der Meijden, B., Bernardini, F., Lederer, A., Dias, R. L. A., et al. (2010) · Science · doi:10.1126/science.1182749 · Cited by 554

Degradation of Human Antimicrobial Peptide LL-37 by Staphylococcus aureus -Derived Proteinases

Sieprawska-Lupa, M., Mydel, P., Krawczyk, K., Wójcik, K., Puklo, M., Lupa, B., Suder, P., Silberring, J., Reed, M., Pohl, J., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4673-4679.2004 · Cited by 551

Direct inactivation of viruses by human granulocyte defensins

Daher, K. A., Selsted, M. E., & Lehrer, R. I. (1986) · Journal of Virology · doi:10.1128/jvi.60.3.1068-1074.1986 · Cited by 533

Novel plasmid-mediated colistin resistance mcr-4 gene in Salmonella and Escherichia coli, Italy 2013, Spain and Belgium, 2015 to 2016

Carattoli, A., Villa, L., Feudi, C., Curcio, L., Orsini, S., Luppi, A., Pezzotti, G., & Magistrali, C. F. (2017) · Eurosurveillance · doi:10.2807/1560-7917.es.2017.22.31.30589 · Cited by 533

Identification of a novel transposon-associated phosphoethanolamine transferase gene, mcr-5, conferring colistin resistance in d-tartrate fermenting Salmonella enterica subsp. enterica serovar Paratyphi B

Borowiak, M., Fischer, J., Hammerl, J. A., Hendriksen, R. S., Szabo, I., & Malorny, B. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx327 · Cited by 533

Human Antimicrobial Peptides and Proteins

Wang, G. (2014) · Pharmaceuticals · doi:10.3390/ph7050545 · Cited by 528

Peptide–membrane interactions and mechanisms of membrane destruction by amphipathic α-helical antimicrobial peptides

Sato, H., & Feix, J. B. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.02.021 · Cited by 522

Broad-Spectrum Anti-biofilm Peptide That Targets a Cellular Stress Response

de la Fuente-Núñez, C., Reffuveille, F., Haney, E. F., Straus, S. K., & Hancock, R. E. W. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004152 · Cited by 521

Capsule Polysaccharide Mediates Bacterial Resistance to Antimicrobial Peptides

Campos, M. A., Vargas, M. A., Regueiro, V., Llompart, C. M., Albertí, S., & Bengoechea, J. A. (2004) · Infection and Immunity · doi:10.1128/iai.72.12.7107-7114.2004 · Cited by 518

Human β-defensins

Pazgier, M., Hoover, D. M., Yang, D., Lu, W., & Lubkowski, J. (2006) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s00018-005-5540-2 · Cited by 514

Antimicrobial Peptide Structure and Mechanism of Action: A Focus on the Role of Membrane Structure

Lee, T.-H., N. Hall, K., & Aguilar, M.-I. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150703121700 · Cited by 512

Identification of Novel Mobilized Colistin Resistance Gene mcr-9 in a Multidrug-Resistant, Colistin-Susceptible Salmonella enterica Serotype Typhimurium Isolate

Carroll, L. M., Gaballa, A., Guldimann, C., Sullivan, G., Henderson, L. O., & Wiedmann, M. (2019) · mBio · doi:10.1128/mbio.00853-19 · Cited by 506

Effects of net charge and the number of positively charged residues on the biological activity of amphipathic α‐helical cationic antimicrobial peptides

Jiang, Z., Vasil, A. I., Hale, J. D., Hancock, R. E. W., Vasil, M. L., & Hodges, R. S. (2008) · Peptide Science · doi:10.1002/bip.20911 · Cited by 505

QSAR-Based Virtual Screening: Advances and Applications in Drug Discovery

Neves, B. J., Braga, R. C., Melo-Filho, C. C., Moreira-Filho, J. T., Muratov, E. N., & Andrade, C. H. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01275 · Cited by 494

A New Era of Antibiotics: The Clinical Potential of Antimicrobial Peptides

Browne, K., Chakraborty, S., Chen, R., Willcox, M. D., Black, D. S., Walsh, W. R., & Kumar, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197047 · Cited by 482

A Dose-Response Study of Antibiotic Resistance in Pseudomonas aeruginosa Biofilms

Brooun, A., Liu, S., & Lewis, K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.640-646.2000 · Cited by 473

Sustainability Challenges in Peptide Synthesis and Purification: From R&D to Production

Isidro-Llobet, A., Kenworthy, M. N., Mukherjee, S., Kopach, M. E., Wegner, K., Gallou, F., Smith, A. G., & Roschangar, F. (2019) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.8b03001 · Cited by 473

Ultrashort antibacterial and antifungal lipopeptides

Makovitzki, A., Avrahami, D., & Shai, Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606129103 · Cited by 468

Emergence of a novel mobile colistin resistance gene, mcr-8 , in NDM-producing Klebsiella pneumoniae

Wang, X., Wang, Y., Zhou, Y., Li, J., Yin, W., Wang, S., Zhang, S., Shen, J., Shen, Z., & Wang, Y. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-018-0124-z · Cited by 460

Inhibition of Bacterial Biofilm Formation and Swarming Motility by a Small Synthetic Cationic Peptide

de la Fuente-Núñez, C., Korolik, V., Bains, M., Nguyen, U., Breidenstein, E. B. M., Horsman, S., Lewenza, S., Burrows, L., & Hancock, R. E. W. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00064-12 · Cited by 459

Polymyxin: Alternative Mechanisms of Action and Resistance

Trimble, M. J., Mlynárčik, P., Kolář, M., & Hancock, R. E. W. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025288 · Cited by 454

Estimation of Direct Healthcare Costs of Fungal Diseases in the United States

Benedict, K., Jackson, B. R., Chiller, T., & Beer, K. D. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy776 · Cited by 438

Local Epidemics Gone Viral: Evolution and Diffusion of the Italian HIV-1 Recombinant Form CRF60_BC

Lai, A., Simonetti, F. R., Brindicci, G., Bergna, A., Di Giambenedetto, S., Sterrantino, G., Mussini, C., Menzo, S., Bagnarelli, P., Zazzi, M., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00769 · Cited by 436

Combating Multidrug‐Resistant Bacteria: Current Strategies for the Discovery of Novel Antibacterials

O'Connell, K. M. G., Hodgkinson, J. T., Sore, H. F., Welch, M., Salmond, G. P. C., & Spring, D. R. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201209979 · Cited by 435

Antibiotic resistance: What is so special about multidrug-resistant Gram-negative bacteria?

Exner, M., Bhattacharya, S., Christiansen, B., Gebel, J., Goroncy‐Bermes, P., Hartemann, P., Heeg, P., Ilschner, C., Krämer, A., Larson, E., et al. (2017) · PubMed · doi:10.3205/dgkh000290 · Cited by 429

PmrAB, a Two-Component Regulatory System of Pseudomonas aeruginosa That Modulates Resistance to Cationic Antimicrobial Peptides and Addition of Aminoarabinose to Lipid A

Moskowitz, S. M., Ernst, R. K., & Miller, S. I. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.2.575-579.2004 · Cited by 418

Climate-induced phenology shifts linked to range expansions in species with multiple reproductive cycles per year

Macgregor, C. J., Thomas, C. D., Roy, D. B., Beaumont, M. A., Bell, J. R., Brereton, T., Bridle, J. R., Dytham, C., Fox, R., Gotthard, K., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12479-w · Cited by 414

Wall Teichoic Acid Function, Biosynthesis, and Inhibition

Swoboda, J. G., Campbell, J., Meredith, T. C., & Walker, S. (2010) · ChemBioChem · doi:10.1002/cbic.200900557 · Cited by 412

Gram-positive and gram-negative bacterial toxins in sepsis: A brief review

Ramachandran, G. (2014) · Virulence · doi:10.4161/viru.27024 · Cited by 411

Lasso Peptides: An Intriguing Class of Bacterial Natural Products

Hegemann, J. D., Zimmermann, M., Xie, X., & Marahiel, M. A. (2015) · Accounts of Chemical Research · doi:10.1021/acs.accounts.5b00156 · Cited by 393

DRAMP 2.0, an updated data repository of antimicrobial peptides

Kang, X., Dong, F., Shi, C., Liu, S., Sun, J., Chen, J., Li, H., Xu, H., Lao, X., & Zheng, H. (2019) · Scientific Data · doi:10.1038/s41597-019-0154-y · Cited by 393

Conformation of gramicidin A

Veatch, W. R., Fossel, E. T., & Blout, E. R. (1974) · Biochemistry · doi:10.1021/bi00723a001 · Cited by 387

The gramicidin ion channel: A model membrane protein

Kelkar, D. A., & Chattopadhyay, A. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.05.011 · Cited by 380

Antimicrobial peptides under clinical investigation

Koo, H. B., & Seo, J. (2019) · Peptide Science · doi:10.1002/pep2.24122 · Cited by 376

Antimicrobial activity of synthetic magainin peptides and several analogues.

Zasloff, M., Martin, B., & Chen, H. C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.3.910 · Cited by 373

Novel plasmid-mediated colistin resistance gene mcr-7.1 in Klebsiella pneumoniae

Yang, Y.-Q., Li, Y.-X., Lei, C.-W., Zhang, A.-Y., & Wang, H.-N. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky111 · Cited by 367

Bacterial strategies of resistance to antimicrobial peptides

Joo, H.-S., Fu, C.-I., & Otto, M. (2016) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2015.0292 · Cited by 360

In Vitro Antibacterial Properties of Pexiganan, an Analog of Magainin

Ge, Y., MacDonald, D. L., Holroyd, K. J., Thornsberry, C., Wexler, H., & Zasloff, M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.4.782 · Cited by 359

Reassessing the Host Defense Peptide Landscape

Haney, E. F., Straus, S. K., & Hancock, R. E. W. (2019) · Frontiers in Chemistry · doi:10.3389/fchem.2019.00043 · Cited by 359

Daptomycin: Another Novel Agent for Treating Infections Due to Drug‐Resistant Gram‐Positive Pathogens

Carpenter, C. F., & Chambers, H. F. (2004) · Clinical Infectious Diseases · doi:10.1086/383472 · Cited by 358

Integrated evolutionary analysis reveals antimicrobial peptides with limited resistance

Spohn, R., Daruka, L., Lázár, V., Martins, A., Vidovics, F., Grézal, G., Méhi, O., Kintses, B., Számel, M., Jangir, P. K., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12364-6 · Cited by 358

Structure, membrane orientation, mechanism, and function of pexiganan — A highly potent antimicrobial peptide designed from magainin

Gottler, L. M., & Ramamoorthy, A. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.10.009 · Cited by 354

New Lipoglycopeptides: A Comparative Review of Dalbavancin, Oritavancin and Telavancin

Zhanel, G. G., Calic, D., Schweizer, F., Zelenitsky, S., Adam, H., Lagacé-Wiens, P. R. S., Rubinstein, E., Gin, A. S., Hoban, D. J., & Karlowsky, J. A. (2010) · Drugs · doi:10.2165/11534440-000000000-00000 · Cited by 352

Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review

Cruz, D. N., Perazella, M. A., Bellomo, R., de Cal, M., Polanco, N., Corradi, V., Lentini, P., Nalesso, F., Ueno, T., Ranieri, V. M., et al. (2007) · Critical Care · doi:10.1186/cc5780 · Cited by 347

Chemical space as a source for new drugs

Reymond, J.-L., van Deursen, R., Blum, L. C., & Ruddigkeit, L. (2010) · MedChemComm · doi:10.1039/c0md00020e · Cited by 347

Antiviral peptides as promising therapeutic drugs

Vilas Boas, L. C. P., Campos, M. L., Berlanda, R. L. A., de Carvalho Neves, N., & Franco, O. L. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03138-w · Cited by 336

Antimicrobial Peptides: Interaction With Model and Biological Membranes and Synergism With Chemical Antibiotics

Hollmann, A., Martinez, M., Maturana, P., Semorile, L. C., & Maffia, P. C. (2018) · Frontiers in Chemistry · doi:10.3389/fchem.2018.00204 · Cited by 334

Ring opening polymerization of α-amino acids: advances in synthesis, architecture and applications of polypeptides and their hybrids

Rasines Mazo, A., Allison-Logan, S., Karimi, F., Chan, N. J.-A., Qiu, W., Duan, W., O’Brien-Simpson, N. M., & Qiao, G. G. (2020) · Chemical Society Reviews · doi:10.1039/c9cs00738e · Cited by 329

Living Polypeptides

Aliferis, T., Iatrou, H., & Hadjichristidis, N. (2004) · Biomacromolecules · doi:10.1021/bm0497217 · Cited by 327

D-Enantiomeric Peptides that Eradicate Wild-Type and Multidrug-Resistant Biofilms and Protect against Lethal Pseudomonas aeruginosa Infections

de la Fuente-Núñez, C., Reffuveille, F., Mansour, S. C., Reckseidler-Zenteno, S. L., Hernández, D., Brackman, G., Coenye, T., & Hancock, R. E. W. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2015.01.002 · Cited by 323

Staphylococcus aureus Resists Human Defensins by Production of Staphylokinase, a Novel Bacterial Evasion Mechanism

Jin, T., Bokarewa, M., Foster, T., Mitchell, J., Higgins, J., & Tarkowski, A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.2.1169 · Cited by 319

Capsule polysaccharide is a bacterial decoy for antimicrobial peptides

Llobet, E., Tomás, J. M., & Bengoechea, J. A. (2008) · Microbiology · doi:10.1099/mic.0.2008/022301-0 · Cited by 312

Diversity of endotoxin and its impact on pathogenesis

Trent, M. S., Stead, C. M., Tran, A. X., & Hankins, J. V. (2006) · Journal of Endotoxin Research · doi:10.1179/096805106x118825 · Cited by 311

Chimeric peptidomimetic antibiotics against Gram-negative bacteria

Luther, A., Urfer, M., Zahn, M., Müller, M., Wang, S.-Y., Mondal, M., Vitale, A., Hartmann, J.-B., Sharpe, T., Monte, F. L., et al. (2019) · Nature · doi:10.1038/s41586-019-1665-6 · Cited by 311

Recombinant production of antimicrobial peptides in Escherichia coli: A review

Li, Y. (2011) · Protein Expression and Purification · doi:10.1016/j.pep.2011.08.001 · Cited by 307

Glycopeptide antibiotics: Back to the future

Butler, M. S., Hansford, K. A., Blaskovich, M. A. T., Halai, R., & Cooper, M. A. (2014) · The Journal of Antibiotics · doi:10.1038/ja.2014.111 · Cited by 303

Delivery of antibiotics with polymeric particles

Xiong, M.-H., Bao, Y., Yang, X.-Z., Zhu, Y.-H., & Wang, J. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.02.002 · Cited by 302

Sepsis: Inflammation Is a Necessary Evil

Nedeva, C., Menassa, J., & Puthalakath, H. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00108 · Cited by 301

Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals?

Brogden, N. K., & Brogden, K. A. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.05.004 · Cited by 300

Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice

Mourtada, R., Herce, H. D., Yin, D. J., Moroco, J. A., Wales, T. E., Engen, J. R., & Walensky, L. D. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0222-z · Cited by 297

Antimicrobial peptide mimics for improved therapeutic properties

Rotem, S., & Mor, A. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.10.020 · Cited by 296

Antimicrobial Peptides: An Introduction

Haney, E. F., Mansour, S. C., & Hancock, R. E. W. (2017) · Methods in Molecular Biology · doi:10.1007/978-1-4939-6737-7_1 · Cited by 296

The antimicrobial peptide ZY4 combats multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii infection

Mwangi, J., Yin, Y., Wang, G., Yang, M., Li, Y., Zhang, Z., & Lai, R. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1909585117 · Cited by 286

mcr-1 and mcr-2 (mcr-6.1) variant genes identified in Moraxella species isolated from pigs in Great Britain from 2014 to 2015

AbuOun, M., Stubberfield, E. J., Duggett, N. A., Kirchner, M., Dormer, L., Nunez-Garcia, J., Randall, L. P., Lemma, F., Crook, D. W., Teale, C., et al. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx286 · Cited by 282

Bacterial Persisters and Infection: Past, Present, and Progressing

Gollan, B., Grabe, G., Michaux, C., & Helaine, S. (2019) · Annual Review of Microbiology · doi:10.1146/annurev-micro-020518-115650 · Cited by 280

Correction: Corrigendum: Genomic inference of the metabolism of cosmopolitan subsurface Archaea, Hadesarchaea

Baker, B. J., Saw, J. H., Lind, A. E., Lazar, C. S., Hinrichs, K.-U., Teske, A. P., & Ettema, T. J. G. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.32 · Cited by 277

Rational Engineering of a Flavoprotein Oxidase for Improved Direct Oxidation of Alcohols to Carboxylic Acids

Pickl, M., Winkler, C., Glueck, S., Fraaije, M., & Faber, K. (2017) · Molecules · doi:10.3390/molecules22122205 · Cited by 274

Solid-phase peptide synthesis: an overview focused on the preparation of biologically relevant peptides

Palomo, J. M. (2014) · RSC Adv. · doi:10.1039/c4ra02458c · Cited by 273

Ribosomal peptide natural products: bridging the ribosomal and nonribosomal worlds

McIntosh, J. A., Donia, M. S., & Schmidt, E. W. (2009) · Natural Product Reports · doi:10.1039/b714132g · Cited by 269

Antibiotics: from prehistory to the present day

Gould, K. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv484 · Cited by 268

Recent advances in design of antimicrobial peptides and polypeptides toward clinical translation

Jiang, Y., Chen, Y., Song, Z., Tan, Z., & Cheng, J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.016 · Cited by 267

Developments in Glycopeptide Antibiotics

Blaskovich, M. A. T., Hansford, K. A., Butler, M. S., Jia, Z., Mark, A. E., & Cooper, M. A. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00258 · Cited by 265

Antibiotics in the clinical pipeline in October 2019

Butler, M. S., & Paterson, D. L. (2020) · The Journal of Antibiotics · doi:10.1038/s41429-020-0291-8 · Cited by 264

Antifungal Peptides as Therapeutic Agents

Fernández de Ullivarri, M., Arbulu, S., Garcia-Gutierrez, E., & Cotter, P. D. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00105 · Cited by 264

De Novo Generation of Cationic Antimicrobial Peptides: Influence of Length and Tryptophan Substitution on Antimicrobial Activity

Deslouches, B., Phadke, S. M., Lazarevic, V., Cascio, M., Islam, K., Montelaro, R. C., & Mietzner, T. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.316-322.2005 · Cited by 262

Advances in Development of Antimicrobial Peptidomimetics as Potential Drugs

Molchanova, N., Hansen, P., & Franzyk, H. (2017) · Molecules · doi:10.3390/molecules22091430 · Cited by 257

Effects of pH and salinity on the antimicrobial properties of clavanins

Lee, I. H., Cho, Y., & Lehrer, R. I. (1997) · Infection and Immunity · doi:10.1128/iai.65.7.2898-2903.1997 · Cited by 254

Thirteen decades of peptide synthesis: key developments in solid phase peptide synthesis and amide bond formation utilized in peptide ligation

Jaradat, D. M. M. (2018) · Amino Acids · doi:10.1007/s00726-017-2516-0 · Cited by 253

Peptide Dendrimers as Artificial Enzymes, Receptors, and Drug-Delivery Agents

Darbre, T., & Reymond, J.-L. (2006) · Accounts of Chemical Research · doi:10.1021/ar050203y · Cited by 250

Cationic Antimicrobial Peptide Resistance in Neisseria meningitidis

Tzeng, Y.-L., Ambrose, K. D., Zughaier, S., Zhou, X., Miller, Y. K., Shafer, W. M., & Stephens, D. S. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.15.5387-5396.2005 · Cited by 249

Characterization of the virulence of a non-RT027, non-RT078 and binary toxin-positive Clostridium difficile strain associated with severe diarrhea

Li, C., Harmanus, C., Zhu, D., Meng, X., Wang, S., Duan, J., Liu, S., Fu, C., Zhou, P., Liu, R., et al. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-018-0211-1 · Cited by 245

Exploitation of syndecan-1 shedding by Pseudomonas aeruginosa enhances virulence

Park, P. W., Pier, G. B., Hinkes, M. T., & Bernfield, M. (2001) · Nature · doi:10.1038/35075100 · Cited by 243

Targeted Killing of Streptococcus mutans by a Pheromone-Guided “Smart” Antimicrobial Peptide

Eckert, R., He, J., Yarbrough, D. K., Qi, F., Anderson, M. H., & Shi, W. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00622-06 · Cited by 238

A Functional dlt Operon, Encoding Proteins Required for Incorporation of d -Alanine in Teichoic Acids in Gram-Positive Bacteria, Confers Resistance to Cationic Antimicrobial Peptides in Streptococcus pneumoniae

Kovács, M., Halfmann, A., Fedtke, I., Heintz, M., Peschel, A., Vollmer, W., Hakenbeck, R., & Brückner, R. (2006) · Journal of Bacteriology · doi:10.1128/jb.00336-06 · Cited by 233

Computer-Aided Design of Antimicrobial Peptides: Are We Generating Effective Drug Candidates?

Cardoso, M. H., Orozco, R. Q., Rezende, S. B., Rodrigues, G., Oshiro, K. G. N., Cândido, E. S., & Franco, O. L. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.03097 · Cited by 232

Bacterial Heterogeneity and Antibiotic Survival: Understanding and Combatting Persistence and Heteroresistance

Dewachter, L., Fauvart, M., & Michiels, J. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.09.028 · Cited by 230

Helical antimicrobial polypeptides with radial amphiphilicity

Xiong, M., Lee, M. W., Mansbach, R. A., Song, Z., Bao, Y., Peek, R. M., Yao, C., Chen, L.-F., Ferguson, A. L., Wong, G. C. L., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1507893112 · Cited by 227

Delivery systems to increase the selectivity of antibiotics in phagocytic cells

Briones, E., Isabel Colino, C., & Lanao, J. M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.10.027 · Cited by 224

Evolutionary causes and consequences of bacterial antibiotic persistence

Bakkeren, E., Diard, M., & Hardt, W.-D. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0378-z · Cited by 224

A brief history of antibiotics and select advances in their synthesis

Nicolaou, K. C., & Rigol, S. (2018) · The Journal of Antibiotics · doi:10.1038/ja.2017.62 · Cited by 222

Peptide synthesis: chemical or enzymatic

Guzman, F., Barberis, S., & Illanes, A. (2007) · Electronic Journal of Biotechnology · doi:10.2225/vol10-issue2-fulltext-13 · Cited by 220

Human Antimicrobial Peptides as Therapeutics for Viral Infections

Ahmed, A., Siman-Tov, G., Hall, G., Bhalla, N., & Narayanan, A. (2019) · Viruses · doi:10.3390/v11080704 · Cited by 220

Salt-Resistant Alpha-Helical Cationic Antimicrobial Peptides

Friedrich, C., Scott, M. G., Karunaratne, N., Yan, H., & Hancock, R. E. W. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1542 · Cited by 219

DADP: the database of anuran defense peptides

Novković, M., Simunić, J., Bojović, V., Tossi, A., & Juretić, D. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts141 · Cited by 218

RiPP antibiotics: biosynthesis and engineering potential

Hudson, G. A., & Mitchell, D. A. (2018) · Current Opinion in Microbiology · doi:10.1016/j.mib.2018.02.010 · Cited by 218

Invited review: Diversity of endotoxin and its impact on pathogenesis

Trent, M. S., Stead, C. M., Tran, A. X., & Hankins, J. V. (2006) · Journal of Endotoxin Research · doi:10.1177/09680519060120040201 · Cited by 211

Approved Glycopeptide Antibacterial Drugs: Mechanism of Action and Resistance

Zeng, D., Debabov, D., Hartsell, T. L., Cano, R. J., Adams, S., Schuyler, J. A., McMillan, R., & Pace, J. L. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026989 · Cited by 211

Peptide IDR‐1018: modulating the immune system and targeting bacterial biofilms to treat antibiotic‐resistant bacterial infections

Mansour, S. C., de la Fuente‐Núñez, C., & Hancock, R. E. W. (2015) · Journal of Peptide Science · doi:10.1002/psc.2708 · Cited by 208

Current scenario of peptide-based drugs: the key roles of cationic antitumor and antiviral peptides

Mulder, K. C. L., Lima, L. A., Miranda, V. J., Dias, S. C., & Franco, O. L. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00321 · Cited by 207

Purification and characterization of eight peptides from Galleria mellonella immune hemolymph

Cytryńska, M., Mak, P., Zdybicka-Barabas, A., Suder, P., & Jakubowicz, T. (2007) · Peptides · doi:10.1016/j.peptides.2006.11.010 · Cited by 204

New Insights Into CRASP-Mediated Complement Evasion in the Lyme Disease Enzootic Cycle

Lin, Y.-P., Frye, A. M., Nowak, T. A., & Kraiczy, P. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00001 · Cited by 204

pH modulates the activity and synergism of the airway surface liquid antimicrobials β-defensin-3 and LL-37

Abou Alaiwa, M. H., Reznikov, L. R., Gansemer, N. D., Sheets, K. A., Horswill, A. R., Stoltz, D. A., Zabner, J., & Welsh, M. J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1422091112 · Cited by 203

Intracellular pharmacodynamics of antibiotics

Carryn, S., Chanteux, H., Seral, C., Mingeot-Leclercq, M.-P., Van Bambeke, F., & Tulkens, P. M. (2003) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(03)00066-7 · Cited by 201

Vancomycin Revisited – 60 Years Later

Rubinstein, E., & Keynan, Y. (2014) · Frontiers in Public Health · doi:10.3389/fpubh.2014.00217 · Cited by 200

Expression systems for heterologous production of antimicrobial peptides

Parachin, N. S., Mulder, K. C., Viana, A. A. B., Dias, S. C., & Franco, O. L. (2012) · Peptides · doi:10.1016/j.peptides.2012.09.020 · Cited by 197

Systemic Host Responses in Severe Sepsis Analyzed by Causative Microorganism and Treatment Effects of Drotrecogin Alfa (Activated)

Opal, S. M., Garber, G. E., LaRosa, S. P., Maki, D. G., Freebairn, R. C., Kinasewitz, G. T., Dhainaut, J.-F., Yan, S. B., Williams, M. D., Graham, D. E., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/375593 · Cited by 194

Rhodococcus aetherivorans BCP1 as cell factory for the production of intracellular tellurium nanorods under aerobic conditions

Presentato, A., Piacenza, E., Anikovskiy, M., Cappelletti, M., Zannoni, D., & Turner, R. J. (2016) · Microbial Cell Factories · doi:10.1186/s12934-016-0602-8 · Cited by 191

Polymyxin B: similarities to and differences from colistin (polymyxin E)

Kwa, A., Kasiakou, S. K., Tam, V. H., & Falagas, M. E. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.5.811 · Cited by 190

Anticandida Activity Is Retained in P-113, a 12-Amino-Acid Fragment of Histatin 5

Rothstein, D. M., Spacciapoli, P., Tran, L. T., Xu, T., Roberts, F. D., Dalla Serra, M., Buxton, D. K., Oppenheim, F. G., & Friden, P. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.5.1367-1373.2001 · Cited by 188

Improved Methods for Classification, Prediction, and Design of Antimicrobial Peptides

Wang, G. (2015) · Methods in Molecular Biology · doi:10.1007/978-1-4939-2285-7_3 · Cited by 187

Cyclization Increases the Antimicrobial Activity and Selectivity of Arginine- and Tryptophan-Containing Hexapeptides

Dathe, M., Nikolenko, H., Klose, J., & Bienert, M. (2004) · Biochemistry · doi:10.1021/bi035948v · Cited by 186

Decoding the Membrane Activity of the Cyclotide Kalata B1

Henriques, S. T., Huang, Y.-H., Rosengren, K. J., Franquelim, H. G., Carvalho, F. A., Johnson, A., Sonza, S., Tachedjian, G., Castanho, M. A. R. B., Daly, N. L., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.253393 · Cited by 182

Metal binding and structure–activity relationship of the metalloantibiotic peptide bacitracin

Ming, L.-J., & Epperson, J. D. (2002) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(02)00464-6 · Cited by 181

Acetone‐Linked Peptides: A Convergent Approach for Peptide Macrocyclization and Labeling

Assem, N., Ferreira, D. J., Wolan, D. W., & Dawson, P. E. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201502607 · Cited by 181

Multitarget Approaches against Multiresistant Superbugs

Gray, D. A., & Wenzel, M. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00001 · Cited by 179

Antimicrobial peptides for combating drug-resistant bacterial infections

Xuan, J., Feng, W., Wang, J., Wang, R., Zhang, B., Bo, L., Chen, Z.-S., Yang, H., & Sun, L. (2023) · Drug Resistance Updates · doi:10.1016/j.drup.2023.100954 · Cited by 665

Antimicrobial Peptides—Mechanisms of Action, Antimicrobial Effects and Clinical Applications

Talapko, J., Meštrović, T., Juzbašić, M., Tomas, M., Erić, S., Horvat Aleksijević, L., Bekić, S., Schwarz, D., Matić, S., Neuberg, M., et al. (2022) · Antibiotics · doi:10.3390/antibiotics11101417 · Cited by 281

Synergizing artificial intelligence and probiotics: A comprehensive review of emerging applications in health promotion and industrial innovation

Han, X., Liu, Q., Li, Y., Zhang, M., Liu, K., Kwok, L.-Y., Zhang, H., & Zhang, W. (2025) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2025.104938 · Cited by 64

Antimicrobial peptides in green coconut water: from nutritional benefits to multifunctional applications for human health

Ngan, H. D., Huy, B. L., Uyen, C. L., Phuong, H. B. T., & Xuan, H. L. (2025) · European Food Research and Technology · doi:10.1007/s00217-025-04754-6 · Cited by 3